Phase I unit /

CRU Hungary Ltd. and Miskolci Semmelweis Hospital and University Teaching Hospital (MISEK) made an agreement in 2014 for collaborating in the Clinical Research field as a Public Private Partnership (PPP) project. MISEK - being a regional hospital in Miskolc - provides diagnostic, therapeutic and intensive care background for CRU’s clinical research activities while CRU invested to develop state of the art clinical research units (Phase II-IV) and a separate state-of-the-art Early Phase Unit, which is the largest accredited Phase I Unit in Hungary.

MISEK as a regional Hospital of Miskolc treats 42 000 patients on 1 325 beds and get 1,25 million ambulatory patient visits in its 167 outpatient units every year. In the field of Infectology, Dermatology and Haematology the Hospital also treats the population of the surrounding counties, as a Regional Center.

  • Phase I-II Proof-of-Concept [POC]
  • Adaptive design studies: healthy volunteer and patient
  • First in Human [FIH]
  • Single Ascending Dose [SAD], Multiple Ascending Dose [MAD]
  • Bioavailabilty/Bioequivalence [BA/BE]
  • Pharmacokinetics/Pharmacodynamics [PK/PD]
  • Dose ranging and Tolerability studies
  • Food Effect studies
  • Drug-Drug interaction studies